Peptide Schedule Research TeamReviewed Apr 20268 Citations
Adjust vial, water, and dose — answer updates live
on a U-100 syringe for a 500mcg dose
Never miss a dose — 500mcg daily, draw 10.0 units on U-100 syringe.
No signup required to use calculator
Sync to any calendar app
The Wolverine Stack (BPC-157 + TB-500) combines two healing peptides in one pre-mixed vial. One published human combination report showed 14/16 patients with significant pain relief. Tens of thousands of community reports back up the science. No dedicated clinical trial exists yet, but this remains the most popular healing stack available.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 500mcg | Daily |
| Moderate | 1mg | Daily |
| Aggressive | 1,500mcg | 2x Daily |
The dosing math on a 10 mg pre-mixed vial (5 mg BPC-157 + 5 mg TB-500) reconstituted with 2 mL bacteriostatic water: 5,000 mcg/mL total (2,500 mcg/mL each component). On a U-100 insulin syringe: 5 units = 250 mcg total, 10 units = 500 mcg total, 20 units = 1,000 mcg total. Start at the beginner dose (500 mcg/day, which is 10 units). Most people tolerate it without issues. If nausea hits, drop to 5 units for a few days and work back up. Inject as close to the injury as you can safely reach subcutaneously. For deeper structures like Achilles or rotator cuff, inject into subcutaneous tissue directly above. BPC-157 benefits from proximity; TB-500 goes everywhere regardless. One thing beginners miss: product quality matters more with blends. Require LC-MS/MS confirmation that both BPC-157 (MW 1419.5 Da) and TB-500 (MW 846.97 Da) are present at correct masses. HPLC alone can't distinguish closely related impurities in peptide blends.
Dosing based on No human clinical data: dose from community anecdote and rat studies — 13 published references.View all sources →
Cross-check your Wolverine Stack (BPC-157 + TB-500) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.